Juha Rinne
jurin@utu.fi +358 50 441 2400 |
- Parkinson-potilaan kognitiivisten oireiden hoito (2025) Parkinson-potilaan hoidon hyvät käytännöt Ellfolk, Ulla; Karrasch, Mira; Rinne, Juha
- Progression of Amyloid Accumulation in Late Adulthood Among People With Childhood-Onset Epilepsy (2025)
- Neurology
- Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study (2025)
- EBioMedicine
- Synaptic Density in Multiple Sclerosis (2025)
- Neurology, Neuroimmunology and Neuroinflammation
- The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions (2025)
- Journal of Neuroinflammation
- Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort (2024)
- NeuroImage: clinical
- Alzheimerin taudin lääkehoito (2024) Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
- Alzheimerin tauti sairautena (2024) Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
- Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial (2024)
- Alzheimer's and Dementia
- Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial (Nature Medicine, (2023), 29, 6, (1437-1447), 10.1038/s41591-023-02326-3) (2024)
- Nature Medicine



